Molecular Partners AG (MOLN) Financials

MOLN Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2026 77.2 million 16.6 million
June 30, 2026 93.3 million 21.1 million
March 31, 2026 109.1 million 23.9 million
Dec. 31, 2025 128.7 million 27.4 million

MOLN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 -12.6 million 1.1 million
June 30, 2026 -13.4 million 1.1 million
March 31, 2026 -18.1 million 1.2 million
Dec. 31, 2025 -17.2 million 1.2 million

MOLN Net Income

No data available :(

MOLN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 68.8 million - 3.3 million
June 30, 2026 83.7 million - 3.8 million
March 31, 2026 98.0 million - 4.2 million
Dec. 31, 2025 117.3 million - 4.6 million

MOLN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 45.9 million
June 30, 2026 48.0 million
March 31, 2026 46.8 million
Dec. 31, 2025 47.2 million

MOLN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 - 9.9 million 4.5 million -
June 30, 2026 25295 11.9 million 5.0 million -
March 31, 2026 - 11.8 million 5.0 million -
Dec. 31, 2025 219840 14.6 million 4.6 million -

MOLN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 - -
June 30, 2026 - 596076
March 31, 2026 - 11.8 million
Dec. 31, 2025 - 809005

MOLN

Price: $3.24

52 week price:
3.25
5.36

Earnings Per Share: -1.68 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Switzerland

Volume: 4126

Market Capitalization: 133.3 million

Links: